Partnership Opportunities
Meet the Leading Minds in Global CAR-TCR Development
The ever-growing cell therapy community continue to strive for durable, safe and accessible treatments for oncology, and are now expanding this goal to autoimmune indications too. To achieve this, developers are putting their trust in industry partners to accelerate development and pipeline progression.
The 9th CAR-TCR Summit was the premier meeting in the cell therapy calendar, which provided an unmatched opportunity to connect with decision-makers from small and large biotech, pharma and academia, to spark connections, foster relationships and demonstrated the attendees' commitment to the shared objective of delivering these life-saving treatments to patients.
Get in touch now to begin discussing your bespoke package for 2025.
“Hanson Wade has the leverage to pull the best speaker line-up. Each Hason Wade team member works hard to meet partners’ requests”
Leyna Zhao, Director - Product Management & Marketing, Agilent Technologies
View the 2024 Floorplan Now!
Orange = SOLD | Grey = Available
View the 9th CAR-TCR Summit 2024 Partnership Prospectus:
What Was New in 2024?
Badge Scanning Technology for Easier Lead Capture
Redesigned
Floorplan for Increased Footfall
Streamlined
Agenda for Increased Audience Size Per Track
“Relevant attendees and informative panels”
Yuki Kato Maves, Associate Director - Product Management, AllCells
Who Did the Attendees Meet in 2024?
1,000+ Cell Therapy Experts from Discovery to Supply Chain
C-Level,
Director Level &
VP Level Attendees
Academics, Small & Large Biotech & Pharma Companies
A Snapshot of the 2024 Speaker Faculty:
Arun Pores Fernando
Director, Business Development, Search & Evaluation, Cell Therapy
Bristol Myers Squibb
Carl June
Richard W. Vague Professor in Immunotherapy, Director, Center for Cellular Immunotherapies
University of Pennsylvania
“High level of presentations, excellent exhibition of manufacturing equipment”
Andrea Zobel, Senior Director Strategy, AmerisourceBergen
